Efficacy and safety of adalimumab after infliximab failure in pediatric Crohn disease.
Fumery M, Jacob A, Sarter H, Michaud L, Spyckerelle C, Mouterde O, Savoye G, Colombel JF, Peyrin-Biroulet L, Gower-Rousseau C, Turck D; EPIMAD Group.
Fumery M, et al. Among authors: michaud l.
J Pediatr Gastroenterol Nutr. 2015 Jun;60(6):744-8. doi: 10.1097/MPG.0000000000000713.
J Pediatr Gastroenterol Nutr. 2015.
PMID: 26000887